Vera Therapeutics, Inc.

Healthcare

NASDAQ:VERA · NASDAQ Global Market

Market Cap $2.46B Beta 0.95 P/E (TTM) -6.6

$34.26 +1.81%

+$0.61 today

52W Low $19.07High $56.05

Vol 0.90M · Avg 1.17M

EPS (TTM)-$5.16

Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+50.66%

Period High

$55.67

Period Low

$19.25

Latest

$34.26

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Pharvaris N.V.

NASDAQ:PHVS

$2.15B

Celldex Therapeutics, Inc.

NASDAQ:CLDX

$2.08B

Harmony Biosciences Holdings, Inc.

NASDAQ:HRMY

$1.99B

Immunome, Inc.

NASDAQ:IMNM

$1.76B

uniQure N.V.

NASDAQ:QURE

$1.74B

Nuvation Bio Inc.

NYSE:NUVB

$1.71B

AbCellera Biologics Inc.

NASDAQ:ABCL

$1.60B

Viridian Therapeutics, Inc.

NASDAQ:VRDN

$1.47B

Biohaven Ltd.

NYSE:BHVN

$1.19B

Janux Therapeutics, Inc.

NASDAQ:JANX

$826.95M

What is the latest VERA filing?

The latest filing shown is 8-K dated Jun 2, 2026.

How many recent filings does VERA have?

Intrinsic Alpha currently shows 20 recent filings for VERA.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.